Background Antipsychotic medication reduces the severity of serious mental illness (SMI)
and improves patient outcomes only when medicines were taken as prescribed …

METHODS A group of 8 experts on the management of schizophrenia and LAIs met to
evaluate the evidence and to develop a set of recommendations regarding the clinical use …

The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …

The long‐term benefit‐to‐risk ratio of sustained antipsychotic treatment for schizophrenia
has recently been questioned. In this paper, we critically examine the literature on the long …

Nonadherence with medication occurs in all chronic medical disorders. It is a particular
challenge in schizophrenia due to the illness's association with social isolation, stigma, and …

Although non‐adherence is common across all branches of medicine, psychotic disorders
pose additional challenges that increase its risk. Despite the importance of non‐adherence …

Despite significant advances in treatment, stigma and discrimination toward persons with
mental illness and drug addiction have remained constant in past decades. Prior work …

Objective: Mobile Health (mHealth) approaches can support the rehabilitation of individuals
with psychiatric conditions. In the current article, we describe the development of a …

About half or more of the patients with chronic psychiatric illnesses, either do not take their
medications correctly, or completely stop taking them. The problem of poor initial compliance …

To assess baseline predictors and consequences of antipsychotic adherence during long-
term treatment of schizophrenia outpatients, data were taken from the 3-year, prospective …